Comparison of Different Therapeutic Effects of T-MIST for Chronic Idiopathic Tinnitus
Table 1
Basic information for comparison between the T-MIST groups ().
Vanishing
Remission
Unchanged
Number
42
146
127
Gender (male/female)
23/19
79/67
75/52
0.699
Age (years)
44.00 (28.75-59.25)
41.50 (28.75-51.00)
48.00 (34.00-55.00)
0.008
Initial onset time (years)
42.54 (22.85-53.67)
38.00 (25.72-49.08)
43.00 (31.50-52.83)
0.020
Left ear/right ear/both ears
8/13/21
56/34/56
39/35/53
0.200
Hearing loss: yes/no
12/30
46/100
36/91
0.835
Course of disease (years)
1.00 (0.50-5.50)
1.00 (0.50-3.00)
2.00 (1.00-5.00)
0.007
THIB
45.00 (25.5-57.00)
40.00 (28.00-40.00)
44.00 (28.00-62.00)
0.855
THIA
33.00 (18.00-42.75)
30.50 (18.00-50.25)
32.00 (16.00-50.00)
0.343
VASB
5.00 (4.00-7.00)
5.00 (4.00-7.00)
5.00 (4.00-7.00)
0.535
VASA
3.00 (2.00-5.00)
4.00 (2.00-5.00)
4.00 (3.00-6.00)
0.107
THID
8.00 (0.00-20.25)
8.00 (2.00-15.00)
4.00 (0.00-13.00)
0.095
VASD
1.00 (0.00-3.00)
1.00 (0.00-2.00)
0.00 (0.00-2.00)
0.035
Tinnitus loudness (dB)
39.00 (20.00-59.50)
43.00 (22.00-58.00)
46.00 (24.00-64.00)
0.181
Tinnitus frequency (Hz)
5047 (4000-7663)
4000 (1260-6082)
3775.00 (1260-5993)
0.016
Average threshold of hearing (dB)
20.00 (14.58-30.00)
18.33 (13.33-31.67)
21.67 (15.00-35.00)
0.136
RI: completely/partially/negative
23/16/3
11/75/60
6/31/90
<0.001
The values are given as median with its interquartile range (25–75th). The values are given as the number of cases. THIB, THIA, VASB, VASA, THID, VASD: THI before treatment, THI after treatment, VAS before treatment, VAS after treatment, THIB-THIA, VASB-VASA; average threshold of hearing: average hearing thresholds of 500 kHz, 1000 kHz, and 2000 kHz; RI: residual inhibition test.
